1. Home
  2. ENOV vs SXI Comparison

ENOV vs SXI Comparison

Compare ENOV & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • SXI
  • Stock Information
  • Founded
  • ENOV 1995
  • SXI 1955
  • Country
  • ENOV United States
  • SXI United States
  • Employees
  • ENOV N/A
  • SXI N/A
  • Industry
  • ENOV Fluid Controls
  • SXI Industrial Machinery/Components
  • Sector
  • ENOV Industrials
  • SXI Industrials
  • Exchange
  • ENOV Nasdaq
  • SXI Nasdaq
  • Market Cap
  • ENOV 2.1B
  • SXI 2.3B
  • IPO Year
  • ENOV 2008
  • SXI N/A
  • Fundamental
  • Price
  • ENOV $32.35
  • SXI $137.89
  • Analyst Decision
  • ENOV Buy
  • SXI Strong Buy
  • Analyst Count
  • ENOV 4
  • SXI 3
  • Target Price
  • ENOV $58.50
  • SXI $231.33
  • AVG Volume (30 Days)
  • ENOV 837.4K
  • SXI 75.4K
  • Earning Date
  • ENOV 05-01-2025
  • SXI 05-01-2025
  • Dividend Yield
  • ENOV N/A
  • SXI 0.85%
  • EPS Growth
  • ENOV N/A
  • SXI N/A
  • EPS
  • ENOV N/A
  • SXI 4.56
  • Revenue
  • ENOV $2,107,623,000.00
  • SXI $717,739,000.00
  • Revenue This Year
  • ENOV $7.09
  • SXI $10.29
  • Revenue Next Year
  • ENOV $6.38
  • SXI $13.91
  • P/E Ratio
  • ENOV N/A
  • SXI $33.14
  • Revenue Growth
  • ENOV 23.45
  • SXI N/A
  • 52 Week Low
  • ENOV $33.73
  • SXI $148.15
  • 52 Week High
  • ENOV $62.79
  • SXI $212.66
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 25.13
  • SXI 20.93
  • Support Level
  • ENOV $36.43
  • SXI $157.40
  • Resistance Level
  • ENOV $38.56
  • SXI $163.10
  • Average True Range (ATR)
  • ENOV 1.39
  • SXI 4.49
  • MACD
  • ENOV -0.42
  • SXI -2.09
  • Stochastic Oscillator
  • ENOV 5.98
  • SXI 3.02

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.

Share on Social Networks: